Skip to main content

NZMS, Invisible Sentinel Reach Veriflow Distribution Deal for New Zealand

NEW YORK (GenomeWeb) – New Zealand Medical and Scientific will distribute Invisible Sentinel's Veriflow assays in New Zealand under an agreement announced today.

NZMS will distribute Invisible Sentinel's product line of assays to detect food pathogens, including Veriflow LS for Listeria species; Veriflow SS for Salmonella species; Veriflow CA for Campylobacter; and Veriflow LM for Listeria monocytogenes. Auckland-based NZMS will also sell Veriflow BRETT, which is used to measure levels of Brettanomyces bruxellensis, a microbe that causes wine spoilage.

Veriflow assays for Escherichia coli 0157:H7 and Shiga toxin-producing E. coli are pending approval by the Association of Analytical Communities.

Financial and other terms of the deal were not disclosed.

"Having achieved market share in North America, we are now entering international markets as well," Invisible Sentinel Co-founder and CEO Nick Siciliano said in a statement. "We intend to grow our business both by applying the versatility of Veriflow technology for additional applications and by expanding our geographic reach."

Last month, the Philadelphia-based firm announced a partnership with Victory Brewing to improve beer production.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.